Writing a Social Prescribing Business Case Commissioners Will Actually Fund

Commissioners do not fund loneliness reduction. They fund reduced demand on services they are already paying for, delivered within a financial year they can account for. If your business case leads with “social isolation is a public health crisis,” you have written a press release, not a business case. Here is how to write the version that gets a yes.

Step 1: identify which budget line you are actually competing against

A social prescribing proposal is never assessed against “doing nothing.” It is assessed against the next-best use of that money — usually another clinical service, a waiting-list initiative, or simply not spending it this year. Before you write a word, find out which budget the commissioner controls and what else is bidding for it.

If you are pitching primary care networks, the comparator is GP appointment capacity. If you are pitching a local authority, the comparator is likely adult social care or public health grant allocations. Write the case in the language of whichever budget you are up against, not in the language of the intervention you want to run.

Step 2: pick outcomes the commissioner is already measuring

Do not introduce a new outcome measure and ask the commissioner to start caring about it. Map your intervention onto something already in their reporting cycle.

What you want to claim	What to lead with instead
“Reduces loneliness”	“Reduces GP contact frequency in a cohort of frequent attenders”
“Improves wellbeing”	“Reduces reliance on unscheduled care among patients flagged for social isolation”
“Builds community connection”	“Diverts low-acuity presentations from clinical time to non-clinical support”

A 2021 systematic review of social prescribing and loneliness found that three of nine included studies reported reductions in GP, emergency, social worker, or inpatient service use alongside the individual-level improvements. That is the number to put in front of a commissioner — not because it is the more important outcome, but because it is the one that maps onto a line they have to defend to their own finance committee.

The self-esteem and confidence gains documented in a separate 2021 systematic review of social prescribing’s effect on individual and community wellbeing are real, and worth including — but frame them as the mechanism, not the headline. Confidence is why service use drops. It is rarely, on its own, why a budget gets released.

What this means in practice: open every social prescribing proposal with the service-use or cost line the commissioner already tracks. Put the wellbeing and connection outcomes in the second paragraph, as the explanation for why the first paragraph is true.

Step 3: state the evidence ceiling before someone else does

Commissioners who have sat through several of these pitches have learned to distrust confident claims about loneliness interventions, because the intervention literature is thin. Naming the limit yourself, early, buys credibility for everything that follows.

Claim	Evidence status
Social isolation and loneliness predict earlier mortality	Strong — large meta-analytic base
Social prescribing improves self-reported confidence and wellbeing	Moderate — consistent across qualitative and mixed-method studies, but few controlled trials
Social prescribing reduces downstream service use	Weak-to-moderate — reported in some studies, heterogeneous designs, small samples
A given local scheme will replicate published effect sizes	Unsupported — no scheme has been tested rigorously enough to promise this

The mortality evidence is solid: Julianne Holt-Lunstad’s 2015 meta-analysis found social isolation carried an odds ratio of 1.29 for early death, loneliness 1.26, living alone 1.32, comparable to other established risk factors, and the effects held even after adjusting for existing health status. The National Academies’ 2020 consensus report used exactly this kind of evidence to argue that health systems should be routinely screening for isolation — a recommendation later echoed in clinician-facing commentary calling for routine assessment in clinical settings. Use this tier of evidence to establish that the underlying problem is real and clinically relevant.

Then say plainly that the intervention evidence is weaker than the problem evidence. A commissioner who has read a National Academies report or the 2023 U.S. Surgeon General’s advisory on social connection knows this already. Trying to smooth over it reads as either naive or evasive, and either one gets your proposal moved to the bottom of the pile.

Step 4: name the failure mode you are pricing against

Give the intervention’s likely failure point a name and a mitigation, in the document itself. Commissioners have seen social prescribing pilots that produced a burst of referrals in month one and near-total attrition by month four — call it the referral cliff. A link worker gets a wave of GP referrals when the scheme launches, works through the backlog, and then referral volume collapses because the mechanism for identifying new candidates was never built into ordinary clinical workflow. The pilot’s numbers look strong for a quarter and then evaporate, and the commissioner who funded it has to explain the drop-off to their own board the following year.

Address this directly in the proposal: describe how referral generation is embedded into routine practice (a flag in the patient record, a standing agenda item in MDT meetings, whatever fits the setting) rather than relying on launch enthusiasm. A commissioner who has been burned by a referral cliff before will notice, specifically, whether you have addressed it.

Step 5: cost the thing they’re actually worried about

Commissioners are rarely worried about whether social prescribing “works” in the abstract. They are worried about three concrete things: whether the referral pathway will overload primary care, whether the outcomes are measurable within the funding period, and whether the scheme is dependent on grant funding that disappears in eighteen months. Address these three, explicitly, in that order, before you get to impact.

A qualitative meta-synthesis of how people experience social prescribing found that participants describe the benefit as extending beyond social contact to a restored sense of participation and purpose, and that structured, purposeful activity appears to work better than unstructured contact. That distinction is useful in a business case for a different reason than the obvious one: it lets you specify what the link worker is actually doing, which makes the cost per participant defensible in a way “connecting people socially” never will.

Step 6: give a measurement plan with a stated limitation

Do not promise a randomised controlled trial you cannot run. Almost none of the loneliness intervention literature clears that bar — randomised evidence in this space is rare enough that a single trial of volunteering among lonely older adults in Hong Kong gets cited repeatedly precisely because controlled designs are so scarce elsewhere. Promising a design you cannot deliver, to a commissioner who will check, is worse than proposing something modest and following through.

Instead, propose a pre-post measure on a validated scale, tied to the service-use outcome from Step 2, with a stated caveat that this cannot establish causation on its own. Commissioners who fund public health programmes are used to this limitation from other interventions. Stating it yourself signals competence rather than weakness.

What this does not solve

None of this fixes the underlying evidence gap: social prescribing has a reasonably strong case for improving individual wellbeing and a much weaker one for reducing system costs, and no amount of skillful framing changes what the studies actually show. This guidance helps you get a proposal funded on terms a commissioner will respect. It does not make the intervention more effective than it is, and a scheme that overpromises on service-use reduction to win funding will have a very uncomfortable conversation at year-end review. The UK’s 2018 national loneliness strategy embedded loneliness measurement into national statistics precisely because ad hoc local claims were not holding up to scrutiny — take the hint, and build your local measurement plan to survive the same kind of scrutiny before someone else applies it.